A Phase 1 Study of S-3304 in Patients With Solid Tumors
| Status: | Completed |
|---|---|
| Conditions: | Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - 85 |
| Updated: | 4/28/2018 |
| Start Date: | November 2001 |
| End Date: | March 12, 2003 |
To determine the maximum tolerated dose and safety profile of S-3304 in patients with biopsy
accessible cancer who have failed previous therapy or to whom no standard therapies are
available. To determine the pharmacokinetic profile of S-3304 in this patient population
accessible cancer who have failed previous therapy or to whom no standard therapies are
available. To determine the pharmacokinetic profile of S-3304 in this patient population
Inclusion criteria:
- Biopsy proven diagnosis of solid tumor(s) with biopsy accessible lesion(s)
- Must be able to tolerate oral medication Exclusion criteria
- Patients with other serious illnesses
- Patients who are receiving treatments
We found this trial at
4
sites
Cleveland Clinic Foundation The Cleveland Clinic (formally known as The Cleveland Clinic Foundation) is a...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials